SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-302644
Filing Date
2014-08-08
Accepted
2014-08-08 13:42:26
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d754892d10q.htm 10-Q 704391
2 EX-31.1 d754892dex311.htm EX-31.1 9464
3 EX-31.2 d754892dex312.htm EX-31.2 9485
4 EX-32.1 d754892dex321.htm EX-32.1 4585
5 EX-32.2 d754892dex322.htm EX-32.2 4606
  Complete submission text file 0001193125-14-302644.txt   4120516

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aegr-20140630.xml EX-101.INS 585616
7 XBRL TAXONOMY EXTENSION SCHEMA aegr-20140630.xsd EX-101.SCH 37033
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aegr-20140630_cal.xml EX-101.CAL 59034
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aegr-20140630_def.xml EX-101.DEF 74954
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aegr-20140630_lab.xml EX-101.LAB 288524
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aegr-20140630_pre.xml EX-101.PRE 195203
Mailing Address 101 MAIN STREET SUITE 1850 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1850 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34921 | Film No.: 141026814
SIC: 2834 Pharmaceutical Preparations